Grown Rogue International (GRUSF) Net Margin Growth (1y) (2010 - 2025)
Grown Rogue International (GRUSF) Net Margin Growth (1y) (2010 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 364.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -82.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4,395.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -538.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9,850.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,292.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -146.00 |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6,173.00 |
| Jun 30, 2025 | 9,962.00 |
| Jan 31, 2023 | 3,190.00 |
| Jan 31, 2022 | 9,109.00 |
| Jul 31, 2021 | 8,650.00 |
| Apr 30, 2021 | 3,547.00 |
| Jan 31, 2021 | 4,301.00 |
| Oct 31, 2020 | 48,612.00 |
| Jul 31, 2020 | 1,064.00 |
| Apr 30, 2020 | -2,251.00 |
| Jan 31, 2020 | 42,972.00 |
| Oct 31, 2019 | -16,574.00 |
| Jul 31, 2019 | 11,585.00 |
| Apr 30, 2019 | 11,427.00 |
| Jan 31, 2019 | -19,321.00 |
| Aug 31, 2014 | -81,150.00 |
| Aug 31, 2013 | -24,459.00 |
| May 31, 2013 | 44,237.00 |
| Feb 28, 2013 | 5,786.00 |
| Aug 31, 2012 | -51,448.00 |